Share
Will Martin
Julier Medical, a medical device company developing a next-generation expandable endovascular catheter platform, has appointed Will Martin as President and Chief Executive Officer.
Martin will lead the company through its next phase of development, commercialization and growth.
Martin brings more than 20 years of experience in the medical device industry, with a background spanning senior leadership, catheter-based technologies and the commercialization of emerging medical technologies. His experience includes leading organizations focused on developing and bringing innovative interventional products to market.
Before joining Julier Medical, Martin served as President and Chief Executive Officer of IRRAS, a neurosurgical company focused on technologies for the treatment of hemorrhagic stroke. IRRAS was subsequently acquired by ClearPoint Neuro.
Earlier in his career, Martin served as General Manager of the Peripheral Vascular business at Philips. He also held senior commercial leadership positions at AtheroMed, Hotspur Technologies and AccessClosure. Each of these companies was subsequently acquired by a leading strategic medical device company.
Throughout his career, Martin has played a role in building and commercializing innovative interventional technologies while developing U.S. and international commercial organizations. His leadership experience also includes guiding emerging medical device companies through important stages of product development, commercialization, financing and strategic growth.
At Julier Medical, Martin is expected to leverage this experience as the company advances its expandable endovascular catheter platform and progresses toward its next stage of development. His appointment strengthens the company’s leadership as it works to advance its technology and expand its position within the medical device market.
